rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    MRK
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      What Does Merck (MRK) Losing Nemtabrutinib Mean For Its Blood Cancer Pipeline?
      3h agoYahoo FinanceMRK
      Top Stock Reports for Merck, Caterpillar & Union Pacific
      6h agoYahoo FinanceCATMRKUNP
      Merck Pulls Plug On Acquired Drug after Safety Review
      11h agoBenzingaMRK
      Merck Ends Nemtabrutinib Development: What's Next for Its Pipeline?
      12h agoYahoo FinanceMRK
      Merck names Douglas Baker as independent lead director
      15h agoInvesting.comMRK
      Thomas H. Glocer to Retire From Merck Board of Directors in May 2027; Douglas M. Baker, Jr. Appointed Independent Lead Director
      15h agoYahoo FinanceMRK
      Merck stops trials of blood cancer drug after risk assessment
      Nov 17ReutersMRK
      Merck halts nemtabrutinib program after trial review
      Nov 17Investing.comMRK
      Merck Announces Update on BELLWAVE Clinical Development Program Evaluating Nemtabrutinib
      Nov 17Yahoo FinanceMRK
      How Investors May Respond To Merck (MRK) Pipeline Progress
      Nov 17Yahoo FinanceMRK
      Merck declares $0.88 quarterly dividend for Q1 2027
      Nov 17Investing.comMRK
      Merck Announces First-Quarter 2027 Dividend
      Nov 17Yahoo FinanceMRK
      Merck Stock's $1.3 Billion China Problem Goes Quiet
      Nov 17Yahoo FinanceMRK
      Roth/MKM cuts Rapid Micro Biosystems stock rating on Merck deal
      Nov 17Investing.comRPIDMRK
      Merck & Co. Inc. stock underperforms Monday when compared to competitors
      Nov 16MarketWatchMRK
      Pennsylvania measles cases rise to 1,561, state health department says
      Nov 16ReutersMRK
      Merck KGaA to acquire Rapid Micro Biosystems for $0.75 per share
      Nov 16Investing.comRPIDMRK
      FDA Rejects Summit's China-Developed Merck Rival; Shares Dive

      Summit Therapeutics stock crashed Monday after the Food and Drug Administration rejected its Merck-rivaling lung cancer drug.

      Nov 16Investor's Business DailySMMTMRK
      Merck KGaA, Darmstadt, Germany Signs Definitive Agreement to Acquire Rapid Micro Biosystems, Advancing Automation in Pharmaceutical Quality Control
      Nov 16Yahoo FinanceMRK
      SLS, IBRX And IOVA Join Merck And Lilly On BlackRock’s Q3 Buy List — A Vanguard Unit Adds All Of Them Too
      Nov 16Yahoo FinanceBLKLLYMRK
      Merck announces European CHMP recommends approval of Enflonsia
      Nov 13Yahoo FinanceMRK
      What Will Decide Merck Stock Over The Next Six Months?
      Nov 13Yahoo FinanceMRK
      What Could Merck (MRK) Gain From Two Positive EU CHMP Opinions?
      Nov 13Yahoo FinanceMRK
      Moderna Issues Cost Outlook Amid Revenue Uncertainty, Stock Falls

      Detailed price information for Merck & Company (MRK-N) from The Globe and Mail including charting and trades.

      Nov 13The Globe and MailMRK
      Oncology Market to Reach USD 732.45 Billion by 2035 as Merck, AstraZeneca, Roche, J&J and GSK Spend Billions on Deals to Beat the Patent Cliff
      Nov 13Yahoo FinanceAZNMRK
      Merck KGaA (XTRA:MRK) Stock Looks About Right On FDA Approval News

      Merck KGaA shares have risen solidly over the past year, yet the longer term picture is still marked by a weak five year return, which puts a spotlight on whether the current price lines up with what the business earns. With fresh product news and portfolio reshaping now in play, the stock invites a closer look at how much of those earnings investors are being asked to pay for today. The share price has declined 27.4% over 5 years, so the current valuation question is how that track record...

      Nov 13Yahoo FinanceMRK
      European panel backs Merck RSV drug for second season use
      Nov 13Investing.comMRK
      EU committee backs Merck’s Welireg-lenvatinib for kidney cancer
      Nov 13Investing.comMRK
      Merck KGaA (MKGAF) Q3 2026 Earnings Call Highlights: Third Guidance Raise Backed by Electronics ...
      Nov 12Yahoo FinanceMRK
      Cantor Fitzgerald reiterates Neutral rating on Merck stock at $155
      Nov 12Investing.comMRK
      StoneX reiterates Hold on Bio-Techne stock as Merck deal nears
      Nov 12Investing.comSNEXTECHMRK
      Merck KGaA Drops Heart Drug as Novartis Trial Flop Sows Doubts
      Nov 12BloombergMRKNVS
      What Merck KGaA (MRK) Said on Its Q3 Earnings Call
      Nov 12Yahoo FinanceMRK
      Merck KGaA raises 2026 outlook as Bio-Techne deal nears completion
      Nov 12Seeking AlphaTECHMRK
      Merck KGaA Q3 2026 slides: strong beat, raised guidance, shares fall
      Nov 12Investing.comMRK
      Earnings call transcript: Merck KGaA beats Q3 2026 estimates, shares slip
      Nov 12Investing.comMRK
      Merck KGaA (MKKGY) Lags Q3 Earnings Estimates
      Nov 12Yahoo FinanceMRK
      Why is Merck KGaA stock rallying today?
      Nov 12Investing.comMRK
      Merck KGaA Lifts Outlook Again on Life Science Strength
      Nov 12BloombergMRK
      Merck KGaA Q3 profit slumps 50%; hikes annual guidance
      Nov 12Yahoo FinanceMRK
      Germany’s Merck Raises Guidance Again on Growth Across Units

      The company said it now expects full-year net sales to range between $23.84 billion and $24.29 billion, against its prior forecast of between $23.29 billion and $24.18 billion.

      Nov 12WSJMRK
      Germany's Merck raises 2026 guidance for third time
      Nov 12ReutersMRK
      Lilly, Gilead Face Near-Term Drug Pricing Risks: EXCLUSIVE - Merck & Co (NYSE:MRK), Eli Lilly (NYSE:LLY)
      Nov 11BenzingaGILDLLYMRK
      Scotiabank Reaffirms Their Buy Rating on Merck & Company (MRK)

      Detailed price information for Merck & Company (MRK-N) from The Globe and Mail including charting and trades.

      Nov 11The Globe and MailMRK
      Merck KGaA therapy for rare tumor approved in U.S. (MKGAF)
      Nov 11Seeking AlphaMRK
      Up 42% since January: Why Merck is defeating the patent cliff
      Nov 11Yahoo FinanceMRK
      Merck (MRK) Could Be 7% Undervalued As MASH Trial Data Lifts Optimism
      Nov 11Yahoo FinanceMRK
      Merck Shares Rose Even As Profit Fell
      Nov 11Yahoo FinanceMRK
      Merck Ebola Vaccine Urged for Wider Use Against Bundibugyo Outbreak in Congo
      Nov 9BloombergMRK
      Merck & Co. Inc. stock rises Monday, still underperforms market
      Nov 9MarketWatchMRK

      This is the newest page. Registered accounts read further back.